Moteur de recherche d’entreprises européennes
Financement britannique (225 439 £) : Validation des bienfaits pour la santé cardiaque d’une nouvelle variété de brocoli améliorée Ukri 01/05/2012 Recherche et innovation du Royaume-Uni, Royaume Uni
Vue d’ensemble
Texte
Validation des bienfaits pour la santé cardiaque d’une nouvelle variété de brocoli améliorée
| Abstract | An innovative broccoli product with a health claim would enable increased consumption of vegetables and improve public health. Broccoli naturally accumulates significant amounts of the phytonutrient glucoraphanin (GR), the dietary source of sulforaphane implicated in mitigating oxidative stress and inflammation. New commercial broccoli varieties, developed with conventional breeding and derived from UK public research, with improved levels of GR pave the way for a commonly consumed vegetable providing health benefits to UK consumers. This proposal will examine the cardiovascular health benefits of a new GR (Beneforté®) broccoli in comparison to standard broccoli. Proof-of-concept has been obtained with a High GR prototype; this study will provide appropriately powered statistical evidence of health benefit to enable accredited claims and value creation for consumers. |
| Category | Collaborative R&D |
| Reference | 101119 |
| Status | Closed |
| Funded period start | 01/05/2012 |
| Funded period end | 31/10/2014 |
| Funded value | £225 439,00 |
| Source | https://gtr.ukri.org/projects?ref=101119 |
Participating Organisations
| MONSANTO UK LIMITED |
£14 433,00 |
| UNIVERSITY OF READING |
£126 134,00 |
| THE INSTITUTE OF FOOD RESEARCH |
£84 872,00 |
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Monsanto UK Ltd., Reading, Royaume Uni.